Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Compass Therapeutics, Inc. (CMPX) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Compass Therapeutics, Inc. (CMPX) on November 12, 2026 is 0.8175 $, −1.53 % on the day. Over 52 weeks the stock traded between 0.6710 $ and 6.88 $; the price now sits 2 % of the way up that range. Over the past year the price changed by −83.37 %. Market capitalization is 148.53 million $, rank 76 among 134 stocks of the same industry with a known capitalization.
Compass Therapeutics, Inc. trades on Nasdaq under the ticker CMPX. The company belongs to the Health care sector. The trading history on this page starts on 5 April 2021.
Over the past 52 weeks CMPX has traded between 0.6710 $ and 6.88 $. As of 12 November 2026 the price stood 2.32% of the way from the 52-week low to the high.
Over one year CMPX shares fell 83.37%; over six months they fell 58.83%. Volatility over 90 days is 92.97%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.9, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
Compass Therapeutics, Inc. reported revenue of 0 $ and a net loss of 73M $ over the last four quarters. Revenue changed by −100.00% year over year. Market capitalisation is 149M $.
CMPX has a return on equity of −44.23%, below the sector median of −40.58%. Return on assets is −38.62%, below the sector median of −30.08%.